Granules India has received an approval for further investment of $20 million in Granules Pharmaceuticals Inc., a wholly owned subsidiary of the company. The board of directors at its meeting held on January 28, 2017 has approved for the same.
Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).